Pregabalin Add-on Treatment: A Randomized, Double-blind, Placebo-controlled, Dose-Response Study in Adults with Partial Seizures
DOI 10.1111/j.0013-9580.2004.31203.x
S Arroyo H Anhut AR Kugler, et al. 2004 Pregabalin 1008-011 international study group. Pregabalin add-on treatment: a randomized, double-blind, placebo-controlled, dose-response study in adults with partial seizures Epilepsia 45 20 27 10.1111/j.0013-9580.2004.31203.x 14692903 10.1111/j.0013-9580.2004.31203.x 1:CAS:528:DC%2BD2cXhtVOhs7w%3D (Pubitemid 38063660)
Pregabalin relieves symptoms of painful diabetic neuropathy: A randomized controlled trial
H Lesser U Sharma La Moreaux RM Poole 2004 Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial Neurology 63 2104 2110 15596757 1:STN:280:DC%2BD2cnitFOjtA%3D%3D (Pubitemid 39636259)
The prevalence of pain in multiple sclerosis: A multicenter cross-sectional study
15365151 1:STN:280:DC%2BD2cvls12itQ%3D%3D
C Solaro G Brichetto MP Amato, et al. 2004 The prevalence of pain in multiple sclerosis: a multicenter cross-sectional study Neurology 63 5 919 921 15365151 1:STN:280:DC%2BD2cvls12itQ%3D%3D
An open-label trial of gabapentin treatment of paroxysmal symptoms in multiple sclerosis patients
9710049 1:CAS:528:DyaK1cXls1agtrg%3D
C Solaro GL Lunardi E Capello, et al. 1998 An open-label trial of gabapentin treatment of paroxysmal symptoms in multiple sclerosis patients Neurology 51 2 609 611 9710049 1:CAS:528:DyaK1cXls1agtrg%3D
Antiepileptic medications in multiple sclerosis: Adverse effects in a three-year follow-up study
DOI 10.1007/s10072-004-0362-9
C Solaro G Brichetto MA Battaglia M Messmer Uccelli GL Mancardi 2005 Antiepileptic medications in multiple sclerosis: adverse effects in a three-year follow-up study Neurol Sci 25 6 307 310 10.1007/s10072-004-0362-9 15729492 10.1007/s10072-004-0362-9 1:STN:280:DC%2BD2M%2FpvVOrsA%3D%3D (Pubitemid 40347907)